7210 Research and experimental development on natural sciences and engineering

Code: 
7210

Most active institutional investors by number of deals

Investor Profile Country Deals
Alta Partners LP United States 55
OrbiMed Advisors LLC United States 49
Healthcare Ventures LLC United States 44
Domain Associates LLC Venture capital firm focused on life sciences companies. United States 43
Novartis Services Inc United States 42
Polaris Venture Partners Inc Multistage venture capital investors with focus Technology, Healthcare and Consumer United States 35
Venrock Associates The venture capital arm of the Rockefeller Family. United States 35
Kleiner Perkins Caufield & Byers LLC Venture capital firm. United States 33
Versant Ventures United States 31
ARCH Venture Partners LP Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startup United States 27
One Liberty Ventures United States 27
Rho Ventures United States 26
Johnson & Johnson Development Corp Inc United States 25
5AM Venture Management LLC United States 24
BioEnterprise United States 24
Novartis Venture Funds The corporate venturing arm of Novartis. Switzerland 24
Pappas Ventures United States 24
Western Technology Investment Venture debt firm investing debt and equity capital in venture-backed technology, healthcare and clean technology companies. United States 24
Bessemer Venture Partners Early stage venture capital firm. United States 23
Flagship Ventures Venture capital firm United States 23

Pages

Most active individual investors by number of deals

Most active acquirers by number of deals

Investor Profile Country Deals
Alexion Pharmaceuticals Inc Complement inhibition for cardiovascular and inflammatory diseases. United States 2
Gilead Sciences Inc A biopharmaceutical company that discovers, develops and commercializes therapeutics. United States 2
Invitrogen Corp United States 2
Abbie Inc 1
Abcam PLC Abcam plc is a producer and distributor of research-grade antibodies and associated products. United States 1
Agilent Technologies Inc 1
Alkermes Inc Ireland 1
Amgen Inc United States 1
Biogen Idec Inc United States 1
Cephalon Inc Global biopharmaceutical company dedicated to discovering, developing and bringing to market medications. United States 1
Human Genome Sciences Inc United States 1
IntegenX Inc Developing equipment for molecular diagnostics United States 1
Johnson & Johnson Development Corp Inc United States 1
MacroGenics Inc A biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases. United States 1
Pfizer Inc United States 1
Pi Ltd 1
Swedish Orphan Biovitrum AB Swedish pharmaceutical company with a product portfolio consisting of some 60 orphan and specialty pharmaceuticals Sweden 1
Syngenta International AG Switzerland 1
Thermo Fisher Scientific Inc United States 1
Vayon Group 1

Acquisitions by industry of acquirer

Selected funding rounds

Date Company Profile Round Ccy Amount
14 Dec 2017 Ginkgo Bioworks DNA design company. Series D USD 275,000,000
1 Sep 2017 Armo BioSciences Inc Late-stage immuno-oncology company. Series C-1 USD 67,000,000
25 Apr 2017 EpimAb Biotherapeutics Biopharmaceutical company focused on bispecific antibodies. Series A USD 25,000,000
12 Dec 2016 Oxford Nanopore Technologies Ltd Developing the GridION system, a new generation of technology that uses nanopores - very small holes created in electrically resistant membranes. Other venture GBP 100,000,000
1 Dec 2016 Novogene Technology Co Ltd Provider of genomic services. Series B CNY 515,000,000
30 Nov 2016 Tetra Discovery Partners Inc Biotechnology company developing treatments for Alzheimer's disease and other brain disorders. Series A USD 5,000,000
18 Oct 2016 Science 37 Inc Provider of technology enabled clinical research solutions. Series B USD 31,000,000
29 Sep 2016 ReadCoor Series A USD 23,000,000
29 Aug 2016 Mitra Biotech Pvt Ltd Developer of personalized cancer treatments. Series B USD 27,400,000
18 Aug 2016 Avelas Biosciences Inc Provider of advance, new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons. Series C USD 20,000,000
1 Aug 2016 PathGroup Inc Provider of comprehensive anatomic, clinical and molecular pathology services. Buyout
8 Jun 2016 Ginkgo Bioworks DNA design company. Series C USD 100,000,000
20 May 2016 Empire Genomics LLC Molecular diagnostics company. Other venture USD 1,750,000
21 Oct 2015 Science 37 Inc Provider of technology enabled clinical research solutions. Series A USD 6,500,000
20 Jul 2015 Oxford Nanopore Technologies Ltd Developing the GridION system, a new generation of technology that uses nanopores - very small holes created in electrically resistant membranes. Other venture GBP 70,000,000
18 May 2015 Abcodia Ltd Clinical stage company engaged in the commercial development of novel, scientifically validated tests for the early detection of cancer. Series B GBP 5,250,000
21 Jan 2015 Green Biologics Ltd Series C USD 42,000,000
21 Jan 2015 Green Biologics Ltd Debt USD 34,000,000
Nov 2014 Lumos Labs Inc Web-based provider of scientifically-tested brain training games Secondary
Nov 2014 Abcodia Ltd Clinical stage company engaged in the commercial development of novel, scientifically validated tests for the early detection of cancer. Other venture GBP 100,000

Pages

Selected acquisitions

Date Company Profile Country Ccy Amount
22 Aug 2016 Medivation Inc United States USD 14,000,000,000
28 Apr 2016 Stemcentrx Inc Cancer drug development company. United States USD 10,200,000,000
18 Nov 2015 AMEE UK Ltd Develops the world's most comprehensive, accurate, and transparent calculation engine for quantifying Greenhouse Gases (GHGs). United Kingdom
Sep 2012 Pasteuria Bioscience Inc Pasteuria Bioscience is addressing agriculture's largest unsolved pest problem: plant-parasitic nematodes. United States
5 Mar 2012 Epitomics Inc United States USD 170,000,000
28 Dec 2011 Enobia Pharma Corp Canada USD 1,100,000,000
1 Dec 2011 BioSystem Development LLC United States
4 Mar 2011 Biovex Inc Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease. United States
3 Feb 2011 GenVault Corp United States
31 Jan 2011 Taligen Therapeutics Inc United States
20 Dec 2010 Arresto BioSciences Inc A biotechnology company, develops medicines to treat cancer and fibrotic diseases United States USD 225,000,000
27 May 2010 Fermentas International Inc High quality molecular biology products company for life sciences research community worldwide. United States
21 May 2009 Cougar Biotechnology Inc United States
Jul 2008 Raven Biotechnologies Inc A biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer. United States
10 Jan 2008 CellzDirect Inc United States
4 Jan 2007 Syntonix Pharmaceuticals Inc A needle-free drug delivery company utilizing the FcRn receptor to transport macromolecules across epithelial barriers in the central airway and into United States
Aug 2006 Corus Pharma Inc A specialty pharmaceutical development company developing and obtaining regulatory approvals of products for respiratory and infectious diseases. United States
12 May 2005 Salmedix Inc United States
21 Mar 2005 Cambridge Biotechnology Ltd Small molecule drugs for pain and obesity. Aquired by Biovitrum AB in April 2005. United Kingdom
2 Apr 2004 Protometrix Inc Biotechnology company developing and commercializing the world's first protein microarrays. United States

Pages

Selected IPOs

Date Company Profile Country
Tularik Inc United States
Seattle Genetics Inc A biotechnology company advancing a broad pipeline of antibody-based therapies United States
Shaman Pharmaceuticals Inc United States
Sonus Pharmaceuticals Inc United States
Telik Inc United States

Selected companies

Company type: 
Biopharmaceutical company focused on bispecific antibodies.
Company type: 
Late-stage immuno-oncology company.
Company type: 
A discovery platform technology focused on APE1/Ref1 pathway to produce a series of novel compounds for cancer treatment.
Company type: 
Developer of protein chips.
Subscribe to RSS - 7210 Research and experimental development on natural sciences and engineering